» Articles » PMID: 30503210

Structure Studies of the CRISPR-Csm Complex Reveal Mechanism of Co-transcriptional Interference

Overview
Journal Cell
Publisher Cell Press
Specialty Cell Biology
Date 2018 Dec 4
PMID 30503210
Citations 66
Authors
Affiliations
Soon will be listed here.
Abstract

Csm, a type III-A CRISPR-Cas interference complex, is a CRISPR RNA (crRNA)-guided RNase that also possesses target RNA-dependent DNase and cyclic oligoadenylate (cOA) synthetase activities. However, the structural features allowing target RNA-binding-dependent activation of DNA cleavage and cOA generation remain unknown. Here, we report the structure of Csm in complex with crRNA together with structures of cognate or non-cognate target RNA bound Csm complexes. We show that depending on complementarity with the 5' tag of crRNA, the 3' anti-tag region of target RNA binds at two distinct sites of the Csm complex. Importantly, the interaction between the non-complementary anti-tag region of cognate target RNA and Csm1 induces a conformational change at the Csm1 subunit that allosterically activates DNA cleavage and cOA generation. Together, our structural studies provide crucial insights into the mechanistic processes required for crRNA-meditated sequence-specific RNA cleavage, RNA target-dependent non-specific DNA cleavage, and cOA generation.

Citing Articles

Single-molecule live-cell RNA imaging with CRISPR-Csm.

Xia C, Colognori D, Jiang X, Xu K, Doudna J Nat Biotechnol. 2025; .

PMID: 39966655 DOI: 10.1038/s41587-024-02540-5.


Mechanistic determinants and dynamics of cA6 synthesis in type III CRISPR-Cas effector complexes.

Jungfer K, Moravcik S, Garcia-Doval C, Knorlein A, Hall J, Jinek M Nucleic Acids Res. 2025; 53(2).

PMID: 39817514 PMC: 11734703. DOI: 10.1093/nar/gkae1277.


Research Progress and Application of Miniature CRISPR-Cas12 System in Gene Editing.

Xuan Q, Wang J, Nie Y, Fang C, Liang W Int J Mol Sci. 2024; 25(23).

PMID: 39684395 PMC: 11641405. DOI: 10.3390/ijms252312686.


Selective degradation of phage RNAs by the Csm6 ribonuclease provides robust type III CRISPR immunity in Streptococcus thermophilus.

Johnson K, Garrett S, Noble-Molnar C, Elgarhi H, Woodside W, Cooper C Nucleic Acids Res. 2024; 52(20):12549-12564.

PMID: 39360614 PMC: 11551762. DOI: 10.1093/nar/gkae856.


Structural basis for the activity of the type VII CRISPR-Cas system.

Yang J, Li X, He Q, Wang X, Tang J, Wang T Nature. 2024; 633(8029):465-472.

PMID: 39143216 DOI: 10.1038/s41586-024-07815-0.


References
1.
Kimanius D, Forsberg B, Scheres S, Lindahl E . Accelerated cryo-EM structure determination with parallelisation using GPUs in RELION-2. Elife. 2016; 5. PMC: 5310839. DOI: 10.7554/eLife.18722. View

2.
Taylor D, Zhu Y, Staals R, Kornfeld J, Shinkai A, van der Oost J . Structural biology. Structures of the CRISPR-Cmr complex reveal mode of RNA target positioning. Science. 2015; 348(6234):581-5. PMC: 4582657. DOI: 10.1126/science.aaa4535. View

3.
Niewoehner O, Jinek M . Structural basis for the endoribonuclease activity of the type III-A CRISPR-associated protein Csm6. RNA. 2016; 22(3):318-29. PMC: 4748810. DOI: 10.1261/rna.054098.115. View

4.
Barrangou R, Fremaux C, Deveau H, Richards M, Boyaval P, Moineau S . CRISPR provides acquired resistance against viruses in prokaryotes. Science. 2007; 315(5819):1709-12. DOI: 10.1126/science.1138140. View

5.
Ramia N, Spilman M, Tang L, Shao Y, Elmore J, Hale C . Essential structural and functional roles of the Cmr4 subunit in RNA cleavage by the Cmr CRISPR-Cas complex. Cell Rep. 2014; 9(5):1610-1617. PMC: 4269474. DOI: 10.1016/j.celrep.2014.11.007. View